Who's to blame for drug shortages? 

And why is Wall Street down on biotech?

We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, STAT Washington correspondent Nicholas Florko joins us to break down what the impeachment inquiry means for the congressional fight over drug prices and the fate of the FDA. Then, Dr. Ben Davies, a University of Pittsburgh urologist, calls in to discuss what happens when key drugs face dangerous shortages. Later, we dig into biotech’s rough third quarter and discuss how things might change before the year’s out.

You can listen to the episode here. To listen to future episodes, be sure to sign up on iTunes, Stitcher, Spotify, or wherever you get your podcasts.